from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1398c/vapB10

LFCtreatmentdescriptionclass of inhibitor

0.589

Amikacinug/mL Amikacintranslation

0.532

Cap5-10ug/mL Capreomycintranslation

1.102

Rox10-50 ug/mL Roxithromycintranslation

-0.380

SM2-5 ug/mL Streptomycintranslation

0.880

Tet5-10 ug/mL Tetracyclinetranslation

-1.896

Rif0.2-5ug/mL Rifampicintranscription

-2.307

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.513

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.931

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.436

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.179

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.226

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.187

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.489

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.148

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.200

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.039

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.566

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.598

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.745

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.196

KCN5-20 ug/mL Potassium cyaniderespiration

0.224

NaN30.2-2 mM Sodium aziderespiration

0.345

Nigericin50 uM Nigericinrespiration

0.093

TRC10-150 ug/mL Triclosanrespiration

0.050

TRZ10-25 ug/mL Thioridazinerespiration

1.511

Valinomycin0.5-10 uM Valinomycinrespiration

0.001

ZnSO42 mM ZnSO4respiration

-1.797

menadione6-10 ug/mL Menadionerespiration

-0.587

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.541

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.740

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.038

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.641

NRP_1Non-replicating persistence stage 1dosRassociated

0.039

Amp0.2mg/mL AmpicillincellWall

-0.283

Cephalexin20-100 ug/mL CephalexincellWall

-0.517

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.832

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.418

EMB10-20 ug/mL EthambutolcellWall

0.174

Eta12-40 ug/mL EthionamidecellWall

0.160

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.034

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.020

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.302

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.920

BZA0.12 mg/mL BenzamidearomaticAmides

0.904

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

1.359

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-1.196

H2O24 mM hydrogen peroxideDNAdamaging

0.290

Levo10 ug/mL LevofloxacinDNAdamaging

-0.925

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.115

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.297

Oflox5-10 ug/mL OfloxacinDNAdamaging

-1.053

UVUV-irradiationDNAdamaging

-0.180

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.817

Antimycin12.5-50 ug/mL Antimycin A?

-0.655

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.718

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.572

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.014

PA8240.2-2 ug/mL PA-824?

0.850

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.100

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.633

Verapamil50 uM Verapamil?

0.071

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.087

methoxatin10-20 ug/mL Methoxatin?